✦ LIBER ✦

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

✍ Scribed by Larry R. Smith; Mary K. Wloch; Ming Ye; Luane R. Reyes; Souphaphone Boutsaboualoy; Casey E. Dunne; Jennifer A. Chaplin; Denis Rusalov; Alain P. Rolland; Cindy L. Fisher; Mohamed S. Al-Ibrahim; Martin L. Kabongo; Roy Steigbigel; Robert B. Belshe; Ernest R. Kitt; Alice H. Chu; Ronald B. Moss

Book ID: 116962401
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 498 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.01.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose ranging of adjuvant and antigen in

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

✍ Wendy Keitel; Nicola Groth; Maria Lattanzi; Michaela Praus; Anne Katrin Hilbert; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 950 KB

Safety and immunogenicity of live attenu

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)

✍ Larisa Rudenko; Julia Desheva; Sergey Korovkin; Alexander Mironov; Andrey Reksti 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 99 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

✍ Jiangtao Lin; Jiansan Zhang; Xiaoping Dong; Hanhua Fang; Jiangting Chen; Nan Su; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 135 KB

Phase I and II randomised trials of the

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

✍ Terry M. Nolan; Peter C. Richmond; Maryanne V. Skeljo; Georgina Pearce; Gunter H 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Safety and immunogenicity of Sinovac’s p

Safety and immunogenicity of Sinovac’s prototype pandemic influenza H5N1 vaccines: a review on clinical trials

✍ Yuan-Zheng Qiu; Wei-Dong Yin 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 110 KB

Safety and immunogenicity of a prototype

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

✍ Terry Nolan; Peter C. Richmond; Neil T. Formica; Katja Höschler; Maryanne V. Ske 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 477 KB